唑来膦酸与伊班膦酸钠治疗恶性肿瘤骨转移疼痛的临床疗效对比分析
2018-12-21张艳芳
张艳芳

[摘要] 目的 对比分析在恶性肿瘤骨转移患者施用伊班膦酸钠与唑来膦酸的疗效和安全性。方法 方便选取内蒙古某医院2016年9月—2018年1月确诊的70例恶性肿瘤骨转移患者,按随机抽签法平均分为实验组,施用伊班膦酸钠;对照组,施用唑来膦酸。观察止痛效果和骨相关事件发生情况。 结果 实验组(21.6±3.1)h 与对照组(51.3±6.9)h相比,伊班磷酸钠起效更快(t=48.5,P<0.05),骨相关事件发生率更低(χ2=4.43,P<0.05),镇痛有效率更高(χ2=4.48,P<0.05),伊班膦酸钠的药物不良反应更低,差异有统计学意义(P<0.05)。结论 伊班磷酸钠对恶性肿瘤骨转移的治疗更安全、舒心,疗效更好。
[关键词] 骨肿瘤;继发原发性;伊班膦酸钠;癌性疼痛;唑来膦酸
[中图分类号] R4 [文献标识码] A [文章编号] 1674-0742(2018)08(c)-0111-03
Comparison of Clinical Efficacy of Zoledronic Acid and Ibandronate in the Treatment of Bone Metastasis Pain in Malignant Tumors
ZHANG Yan-fang
Department of Pharmacy, Affiliated People's Hospital, Inner Mongolia Medical University, Hohhot, Inner Mongolia, 010020 China
[Abstract] Objective To compare the efficacy and safety of ibandronate and zoledronic acid in patients with malignant bone metastases. Methods Convenient select a total of 70 patients with malignant bone metastases diagnosed from September 2016 to January 2018 in a hospital in Inner Mongolia were randomly divided into experimental group and ibandronate sodium group. The control group was given zoledronic acid. Observed pain relief and bone related events. Results In the experimental group (21.6± 3.1)h, compared with the control group (51.3±6.9)h, the effect of sodium iban phosphate was faster (t=48.5, P<0.05), and the incidence of bone-related events was lower (χ2=4.43, P<0.05), the analgesia was more effective (χ2=4.48, P<0.05), and the adverse drug reaction of ibandronate was lower, with the difference was statistical significance (P<0.05). Conclusion Iban sodium phosphate is more safe and comfortable for the treatment of bone metastases of malignant tumors.
[Key words] Bone neoplasm; Secondary primary; Ibandronate; Cancer pain; Zoledronic acid
近年來,人们谈癌色变,癌症是全球主要死因之一。细胞不受控制的增长和扩散将成为癌细胞。它可影响人体的几乎任何部分。肿瘤常常侵入周围的组织并可转移到其它部位[1]。在晚期肿瘤中有一个常见的并发症:骨转移,尤其是在肺癌、肾癌、乳腺癌、前列腺癌和甲状腺癌等,它的发生率在30%~75%左右[1]。恶性肿瘤骨转移患者容易出现病理性骨折、骨性疼痛甚至脊髓压迫等骨相关事件,患者的生活体验、生活质量常常受到明显的影响[2]。在临床上,针对而恶性肿瘤骨转移,使用放疗手段是主要治疗手段之一,在放疗期间联合使用抗溶骨治疗药物双膦酸盐类药物等有着明显的效果[3],为了探讨在恶性肿瘤骨转移患者中伊班膦酸钠与唑来膦酸有效性和安全性,该研究针对内蒙古该医院2016年9月—2018年1月收治的70例恶性肿瘤骨转移患者进行分析,现报道如下。
1 资料与方法
1.1 一般资料
研究对象是方便选取内蒙古该医院的70例恶性肿瘤骨转移患者。……
